0001140361-16-059376.txt : 20160329 0001140361-16-059376.hdr.sgml : 20160329 20160329181624 ACCESSION NUMBER: 0001140361-16-059376 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160325 FILED AS OF DATE: 20160329 DATE AS OF CHANGE: 20160329 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Asterias Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001572552 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461047971 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-456-3805 MAIL ADDRESS: STREET 1: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wirth Edward CENTRAL INDEX KEY: 0001532558 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36646 FILM NUMBER: 161536579 MAIL ADDRESS: STREET 1: C/O INVIVO THERAPEUTICS HOLDING CORP. STREET 2: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc1.xml FORM 4 X0306 4 2016-03-25 0 0001572552 Asterias Biotherapeutics, Inc. AST 0001532558 Wirth Edward 6300 DUMBARTON CIRCLE FREMONT, CA 94555 0 1 0 0 Chief Medical Officer Restricted Stock Units 2016-03-25 4 A 0 21882 0 A 21882 D The RSUs were granted by the Board of Directors of the Company. The RSUs vest in four quarterly installments over a 12-month period. /s/ Edward Wirth 2016-03-28